FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ – BioMarin Pharmaceutical Inc. Transaction History
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ portfolio value:
$97.11M
portfolio value
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -7.32% | -90.46K shares | -5.32M | $84.77 | 1.14M |
| Q2 2022 | share | Increase | +0.09% | 1.05K shares | 7.21M | $82.87 | 1.23M |
| Q1 2022 | share | Increase | +7.99% | 91.37K shares | -5.82M | $77.1 | 1.23M |
| Q4 2021 | share | Increase | +93.21% | 551.72K shares | 55.29M | $89.08 | 1.14M |
| Q3 2021 | share | Increase | 0.00% | 591.90K shares | 45.74M | $77.29 | 591.90K |
| Q1 2019 | share | Decrease | -100.00% | -4.59K shares | -391K | $88.83 | 0 |
| Q4 2018 | share | 0.00% | 0 shares | -54K | $85.15 | 4.59K | |
| Q3 2018 | share | 0.00% | 0 shares | 13K | $96.97 | 4.59K | |
| Q2 2018 | share | Decrease | -4.18% | -200 shares | 44K | $94.2 | 4.59K |
| Q1 2018 | share | Decrease | -20.03% | -1.2K shares | -146K | $81.07 | 4.79K |
| Q4 2017 | share | Decrease | -2.60% | -160 shares | -38K | $89.17 | 5.99K |
| Q3 2017 | share | Decrease | -20.65% | -1.6K shares | -132K | $93.07 | 6.15K |
| Q2 2017 | share | Decrease | -19.69% | -1.9K shares | -143K | $90.82 | 7.75K |
| Q1 2017 | share | 0.00% | 0 shares | 48K | $87.78 | 9.65K | |
| Q4 2016 | share | 0.00% | 0 shares | -94K | $82.84 | 9.65K | |
| Q3 2016 | share | Increase | +3.21% | 300 shares | 166K | $92.52 | 9.65K |
| Q2 2016 | share | Increase | +2.47% | 225 shares | -26K | $77.8 | 9.35K |
| Q1 2016 | share | Increase | 0.00% | 9.12K shares | 753K | $82.48 | 9.12K |